Leonard W Seymour (Leonard Seymour, Len Seymour, Len W Seymour)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Immune Response

Top Venues

Journal for immunotherapy of cancer

Journal of tissue engineering and regenerative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Kok-Ting Wan, Ricardo A Fernandes, Leonard W Seymour
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent? Journal for immunotherapy of cancer 11 (8) (2023)
Si-Yuen Lee, Julian George, David Nagel, Hua Ye, Leonard W Seymour
Optogenetically Engineered Neurons Differentiated from Human SH-SY5Y Cells Survived and Expressed ChR2 in 3D Hydrogel. Biomedicines 10 (7) (2022)
Ahmet Hazini, Kerry Fisher, Leonard W Seymour
Deregulation of HLA-I in cancer and its central importance for immunotherapy. Journal for immunotherapy of cancer 9 (8) (2022)
Weiheng Su, Maria I Patrício, Margaret R Duffy, Jakub M Krakowiak, Leonard W Seymour, Ryan Cawood
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination. Nature communications 13 (1) (2022)
Kerry Fisher, Ahmet Hazini, Leonard W Seymour
Tackling HLA Deficiencies Head on with Oncolytic Viruses. Cancers 13 (4) (2021)
Richard Baugh, Hena Khalique, Leonard W Seymour
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers 12 (12) (2020)
Tzveta D Pokrovska, Egon J Jacobus, Rathi Puliyadi, Remko Prevo, Sally Frost, Arthur Dyer, Richard Baugh, Gonzalo Rodriguez-Berriguete, Kerry Fisher, Giovanna Granata, Katharine Herbert, William K Taverner, Brian R Champion, Geoff S Higgins, Leonard W Seymour, Janet Lei-Rossmann
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase. Cancers 12 (4) (2020)
Iris Yousaf, Jakob Kaeppler, Sally Frost, Leonard W Seymour, Egon J Jacobus
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion. Cancers 12 (4) (2020)
Eleanor M Scott, Egon J Jacobus, Brian Lyons, Sally Frost, Joshua D Freedman, Arthur Dyer, Hena Khalique, William K Taverner, Alison Carr, Brian R Champion, Kerry D Fisher, Leonard W Seymour, Margaret R Duffy
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples. Journal for immunotherapy of cancer 7 (1) (2019)
Si-Yuen Lee, Julian H George, David A Nagel, Hua Ye, Gray Kueberuwa, Leonard W Seymour
Optogenetic control of iPS cell-derived neurons in 2D and 3D culture systems using channelrhodopsin-2 expression driven by the synapsin-1 and calcium-calmodulin kinase II promoters. Journal of tissue engineering and regenerative medicine 13 (3) (2019)
Joshua D Freedman, Joachim Hagel, Eleanor M Scott, Ioannis Psallidas, Avinash Gupta, Laura Spiers, Paul Miller, Nikolaos I Kanellakis, Rebecca Ashfield, Kerry D Fisher, Margaret R Duffy, Leonard W Seymour
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies. EMBO molecular medicine 9 (8) (2018)
Janet Lei, Egon J Jacobus, William K Taverner, Kerry D Fisher, Silvio Hemmi, Katy West, Lorna Slater, Fred Lilley, Alice Brown, Brian Champion, Margaret R Duffy, Leonard W Seymour
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. Journal for immunotherapy of cancer 6 (1) (2018)